- Association between Body Composition Characteristics and Bone Mineral Density across Menopausal Transition Stages
-
Kaur M, Kaur R
- KMID: 2568030
- J Menopausal Med.
- 2025 Apr;31(1):12-20.
- doi: 10.6118/jmm.24021
Objectives: This cross-sectional study assessed the association between body composition characteristics and bone mineral density (BMD) across different menopausal transition stages. Methods: In total, 320 rural women aged 45–60 years were... -
- CITED
-
- Close
- SHARE
-
- Close
- Changes in Sleep Quality after Hormone Replacement Therapy with Micronized Progesterone in Japanese Menopausal Women: A Pilot Study
-
Ogawa M, Makita K, Takamatsu K, Takahashi T
- KMID: 2568033
- J Menopausal Med.
- 2025 Apr;31(1):45-50.
- doi: 10.6118/jmm.24030
Sleep disturbances are common among women during menopause. Hormone replacement therapy (HRT) using micronized progesterone (MP) may improve sleep, owing to its neurosteroid effects. Studies on the impact of oral... -
- CITED
-
- Close
- SHARE
-
- Close
- Asia-Pacific Menopause Federation Consensus Statement on the Management of Menopause 2024
-
Ang SB, Sugianto SRS, Tan FCJH, Davison S, Yu Q, Terauchi M, Kim MR, Shah J, Nasreen SZA, Ho CM, Sodnomdorj E, Siregar MFG, Hussain R, Noblejas-Gamilla MCZ, Chua Y, Tsai YC, Jaisamrarn U
- KMID: 2568029
- J Menopausal Med.
- 2025 Apr;31(1):3-11.
- doi: 10.6118/jmm.25104
Objectives: This study aimed to achieve expert consensus on menopause management in the Asia-Pacific region, taking into account patient diversity, the latest evidence, and current treatment options. Methods: A focused literature... -
- CITED
-
- Close
- SHARE
-
- Close
- Ashwagandha and Shatavari Extracts Dose-Dependently Reduce Menopause Symptoms, Vascular Dysfunction, and Bone Resorption in Postmenopausal Women: A Randomized, Double-Blind, Placebo-Controlled Study
-
Pingali U, Nutalapati C, Wang Y
- KMID: 2568031
- J Menopausal Med.
- 2025 Apr;31(1):21-34.
- doi: 10.6118/jmm.24025
Objectives: In this study, we investigate the effects of dietary supplementation with standardized aqueous extracts of shatavari (Asparagus racemosus, Ar), ashwagandha (Withania somnifera, Ws), or their combination on menopausal symptoms,... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessing the Noninferiority of the Spermidine Hyaluronate Complex Relative to 17β-Estradiol Treatment in the Ovariectomized Murine Model of Vulvovaginal Atrophy
-
Ghisalberti CA, Tezze C
- KMID: 2568032
- J Menopausal Med.
- 2025 Apr;31(1):35-44.
- doi: 10.6118/jmm.24022
Objectives: Vulvovaginal atrophy (VVA) presents significant challenges in postmenopausal women. VVA is typically managed either with hormonal-estrogenic therapy or nonpharmacologically with hyaluronic acid (HA) treatments. This study has investigated an... -
- CITED
-
- Close
- SHARE
-
- Close
- Implementation and Clinical Implications of the Asia-Pacific Menopause Federation Consensus Statement on the Management of Menopause 2024
-
Ho CM
- KMID: 2568028
- J Menopausal Med.
- 2025 Apr;31(1):1-2.
- doi: 10.6118/jmm.25107
-
- CITED
-
- Close
- SHARE
-
- Close
